Abstract
Several reports have described excitatory GABA transmission in the suprachiasmatic nucleus (SCN), the master pacemaker of circadian physiology. However, there is disagreement regarding the prevalence, timing, and neuronal location of excitatory GABA transmission in the SCN. Whether GABA is inhibitory or excitatory depends, in part, on the intracellular concentration of chloride ([Cl−]i). Here, using ratiometric Cl− imaging, we have investigated intracellular chloride regulation in AVP and VIP-expressing SCN neurons and found evidence suggesting that [Cl−]i is higher during the day than during the night in both AVP+ and VIP+ neurons. We then investigated the contribution of the cation chloride cotransporters to setting [Cl−]i in these SCN neurons and found that the chloride uptake transporter NKCC1 contributes to [Cl−]i regulation in SCN neurons, but that the KCCs are the primary regulators of [Cl−]i in SCN neurons. Interestingly, we observed that [Cl−]i is differentially regulated between AVP+ and VIP+ neurons-a low concentration of the loop diuretic bumetanide had differential effects on AVP+ and VIP+ neurons, while blocking the KCCs with VU0240551 had a larger effect on VIP+ neurons compared to AVP+ neurons.
Similar content being viewed by others
Introduction
The suprachiasmatic nucleus (SCN) of the anterior hypothalamus is the master pacemaker of the circadian system. Besides a cohort of neuropeptides, SCN neurons synthesize and package the neurotransmitter GABA. GABA transmission regulates synaptic input from the RHT1, mediates phase shifts2, 3, regulates firing frequency4, and contributes to circadian synchrony5,6,7,8,9.
GABA is the primary inhibitory neurotransmitter in the central nervous system, but has been observed to be excitatory during embryonic and neonatal development, in certain pathologies, as well as in several areas of the adult brain10,11,12. Interestingly, excitatory GABA transmission has been observed in the mature SCN6, 7, 13,14,15,16,17,18,19,20. However, reports have disagreed on the prevalence, timing, and neuronal location of excitatory GABA transmission. GABA has been reported to be exclusively inhibitory, inhibitory during the day and excitatory during the night, and excitatory during the night and inhibitory during the day7, 13,14,15, 17, 20,21,22. Additionally, the proportion of neurons within the SCN neural network that are excited by GABA may be involved in encoding day length18, 23.
The GABAA receptor is permeable to both Cl− and HCO3 − ions with a relative permeability ratio of approximately 0.824,25,26. Because the GABAA receptor is primarily permeable to Cl− ions, whether GABA is depolarizing or hyperpolarizing depends on the intracellular concentration of chloride ([Cl−]i) and the membrane potential. [Cl−]i is regulated by a family of cation chloride cotransporters (CCCs) which use the concentration gradients of Na+ and K+ ions to transport Cl− ions into (the sodium-potassium-chloride cotransporter 1, NKCC1) or out of (the potassium-chloride cotransporters, KCC) neurons. Normally, [Cl−]i is kept low in neurons by the action of the neuron-specific27, 28 isotonically-active29,30,31 KCC2. However, a role for NKCC1 in [Cl−]i regulation has been demonstrated in the SCN—blocking NKCC1 with bumetanide decreased the amplitude of GABA-induced Ca2+ transients15, 16, 18 and hyperpolarized the GABAergic reversal potential15, 17.
Interestingly, immunohistochemistry has revealed differential expression of chloride transporters throughout the SCN32. KCC2 expression was most dense in the ventrolateral SCN, and correlated with vasoactive intestinal peptide (VIP) expression. Alternatively, KCC3 and KCC4 expression was concentrated in the dorsomedial SCN. NKCC1 was expressed throughout the SCN, but was concentrated in the dorsomedial SCN, and correlated with vasopressin (AVP) expression. The differential expression of the CCCs throughout the SCN suggests that [Cl−]i and the GABAergic equilibrium potential (EGABA) may vary regionally throughout the SCN. Indeed, Albus et al. observed that GABA is exclusively inhibitory in the ventral SCN, but is excitatory in the dorsal SCN during the late day and early night6. Similarly, GABA-induced Ca2+ transients were found to be most prevalent in the dorsomedial SCN16, and using the Cl−-sensitive dye MQAE, [Cl−]i was found to be elevated in the dorsomedial SCN9. Therefore, there is mounting evidence to support the idea that subpopulations of SCN neurons differ in their regulation of the intracellular chloride concentration.
In this work, we used epifluorescent imaging of a genetically-encoded chloride indicator to examine regional and circadian regulation of [Cl−]i in the SCN. Cl-Sensor is a ratiometric chloride indicator composed of a CFP moiety linked to a YFP moiety whose emission is sensitive to chloride in a physiological range (YFPCl). Ratiometric Cl− imaging allows estimation of [Cl−]i from multiple cells simultaneously without disrupting the native cellular milieu. Using a transgenic strategy, we targeted Cl-Sensor to AVP or VIP-expressing SCN neurons, and were able to detect both transient and persistent changes in [Cl−]i.
Our results indicate that GABAA receptor activation elicits Cl− influx in AVP+ and VIP+ neurons in the SCN. Accordingly, we show that the KCCs play a major role in [Cl−]i regulation in SCN neurons, while the chloride importer NKCC1 has a relatively minor role in setting resting [Cl−]i. Further, we show that [Cl−]i is differentially regulated in AVP and VIP-expressing neurons.
Results
Vasoactive intestinal peptide (VIP) and vasopressin (AVP) mark the “core” and “shell” partition that has served as a useful anatomical model for dissecting SCN function. Generally, sensory inputs project to the ventrolateral SCN core, while core neurons synapse unto neurons in the dorsomedial shell. Several reports have suggested that excitatory GABA transmission may correlate with this anatomical feature13,14,15, 17, 20. Therefore, we performed Cl− imaging in VIP+ and AVP+ neurons of the SCN to look for differences in [Cl−]i regulation between these two populations of neurons. To measure [Cl−]i in SCN neurons, we used a newly-developed Cre-inducible mouse line, with a floxed Cl-Sensor allele inserted into the Rosa26 locus33. To obtain Cl-Sensor expression in the SCN, we crossed these mice with either VIP-IRES-Cre mice or AVP-IRES-Cre mice to give Cl-Sensor expression in either VIP+ or AVP+ neurons34, 35. The resultant VIP::Cl-Sensor mice displayed Cl-Sensor expression in the ventrolateral SCN, while the AVP::Cl-Sensor mice displayed Cl-Sensor expression in the dorsomedial SCN, as expected for VIP and AVP expression (Fig. 1A,B 36).
Several studies have indicated that excitatory GABA transmission demonstrates circadian rhythmicity13, 14, 16, 17, 20. Therefore, we first compared baseline values of RCl during the day (ZT 2 to 8) and night (ZT 12 to 18) in AVP+ and VIP+ SCN neurons. Interestingly, RCl was higher during the day in both AVP+ (generalized estimating equations (GEE), p < 0.05) and VIP+ (GEE, p < 0.001) neurons (Fig. 1E) suggesting that [Cl−]i is higher during the day in these neurons. Several reports have described regional variability of excitatory GABA transmission, with some agreement that it is more common in the dorsal SCN, suggesting that this phenomenon may be specific to AVP+ neurons. Indeed, in the nearby paraventricular nucleus, Haam et al. observed that AVP+ neurons had a more depolarized EGABA relative to their AVP− neighbors37. To determine whether AVP+ neurons demonstrate higher [Cl−]i relative to VIP+ neurons, we compared baseline RCl values between VIP+ and AVP+ neurons, but found no significant difference in RCl during either the day or the night (Fig. 1E).
A hyperpolarizing action of GABA will elicit Cl− influx, while a depolarizing action will elicit Cl− efflux. To assess the polarity of GABA transmission in SCN neurons, we performed puff applications of the GABAA agonist isoguvacine in the presence of 2 µM TTX to block potential polysynaptic effects. In response, RCl increased in AVP+ neurons during the day and night, indicative of Cl− influx and inhibitory GABA transmission (Fig. 2, top row). Cl− influx was also observed in VIP+ neurons during both the day and the night (Fig. 2, bottom row). These results indicate that GABA is inhibitory in both AVP+ and VIP+ SCN neurons. Interestingly, these GABAA-induced Cl− transients lasted for minutes, much longer than expected for GABAA-induced currents, but similar to the timecourse of Cl− transients reported in other cells38,39,40. The timecourse of these Cl− transients may represent the activity of chloride transporters. Indeed, it has been shown that transient shifts in GABA polarity can last for minutes and that chloride transporters mediate this equilibration process41,42,43.
Therefore, we next examined the degree to which the CCCs set [Cl−]i in SCN neurons. Since our GABAA-induced Cl− transients indicated inhibitory Cl− influx upon GABAA receptor activation, we first investigated the contribution of KCC2, the neuron-specific CCC responsible for keeping [Cl−]i levels low in neurons throughout the brain. To test for the activity of KCC2 in setting resting [Cl−]i we used VU0240551, an antagonist that selectively targets the KCCs44. VU increased RCl by 0.18 in AVP+ and by 0.27 in VIP+ neurons (Fig. 3A,B). Based on our calibration curve (Supplementary Fig. 1), we estimate these changes in RCl to reflect a 15 mM increase in [Cl−]i in AVP+ neurons and a 29 mM increase in VIP+ neurons. VU had a significantly greater effect in VIP+ neurons compared to AVP+ neurons (GEE, p < 0.05), but there were no day/night differences within neuron type (Fig. 3C). Because several Cl− transporters are also transporters for the bicarbonate ion, we wondered if removing bicarbonate ions from the extracellular solution might alter [Cl−]i and therefore the efficacy of VU. Therefore, we repeated VU application in a separate set of experiments using a HEPES-buffered solution (Fig. 3D). Blocking the KCCs with VU gave a pattern of results similar to that observed with solution containing bicarbonate. VU elicited an increase in RCl in all conditions, indicative of [Cl−]i increase. When comparing the effect of VU across solutions, we observed a difference in the amplitude of VU’s effect in AVP+ neurons during the day (two-sample z-test, p < 0.05). Furthermore, experiments in HEPES solution revealed a day/night difference in the effect of VU that was not present in the bicarbonate solution (Fig. 3D, GEE, p < 0.05). In a separate set of experiments, we examined the effect of VU on the GABAergic reversal potential (EGABA) using perforated-patch recording. In these experiments, VU elicited a depolarization of EGABA by approximately 23 mV (paired t-test, p < 0.001), and slowed the recovery of resting EGABA after Cl− loading (paired t-test, p < 0.05) (see Supplementary Fig. 2). Collectively, we interpret these findings to indicate that the KCC family of chloride cotransporters play a major role in [Cl−]i regulation in SCN neurons.
Previous studies have implicated NKCC1 in [Cl−]i regulation in SCN neurons15,16,17,18, 32. To test for a contribution of NKCC1 to resting [Cl−]i, we used the loop diuretic bumetanide which selectively targets NKCC1 when used at 10 µM45. Bumetanide increased RCl in AVP+ neurons by approximately 0.04 (~4 mM) and decreased RCl in VIP+ neurons by 0.04 (~3 mM) (Fig. 4). These changes were small but significantly different from baseline (GEE, p < 0.005). As with VU, we observed differences in the effect of bumetanide between AVP+ and VIP+ neurons (GEE, p < 0.001), but no day/night differences within neuron type. Surprisingly, bumetanide elicited a small increase in [Cl−]i in AVP+ neurons, contrary to its expected role in blocking Cl− uptake. This result may be due to off-target effects of bumetanide, which is known to inhibit the KCCs at higher concentrations10, 44. In a separate series of experiments, we tested the efficacy of bumetanide in a HEPES-buffered solution, which should diminish Cl−/HCO3 − exchange. In HEPES, bumetanide reduced RCl in VIP+ neurons but had little effect on AVP+ neurons (Fig. 4D). However, the effect of bumetanide on AVP+ neurons was significantly greater in the bicarbonate-buffered solution compared to the HEPES-buffered solution (two-sample z-test, p < 0.05). As in the bicarbonate-buffered experiments, bumetanide elicited a greater effect in VIP+ neurons compared to AVP+ neurons (GEE, p < 0.05). Using perforated-patch recording, we also investigated the effect of bumetanide on EGABA. In these experiments, bumetanide did not significantly alter EGABA or the timecourse for the recovery of EGABA following a Cl− depletion protocol (Supplementary Fig. 3). Overall, we observed relatively small effects of bumetanide compared to VU, suggesting that the KCCs are the major regulators of resting [Cl−]i in SCN neurons.
The previous results indicate that both NKCC1 and the KCC family of cotransporters contribute to resting [Cl−]i in SCN neurons. We next investigated how these cotransporters interact to regulate [Cl−]i. As discussed, blocking the KCCs with VU resulted in a substantial increase in RCl (Fig. 3). However, because of the relatively minor effect of bumetanide, it was not clear what Cl− uptake pathways were mediating the effect of VU. In order to determine if NKCC1 mediates Cl− uptake in the absence of the KCCs, we applied VU after bumetanide treatment (Fig. 5A). The effect of VU was largely occluded in the presence of bumetanide (Fig. 5A,B). Therefore, although NKCC1 has a relatively minor role in setting resting [Cl−]i, it does constitute a tonic Cl− influx pathway in SCN neurons. Conversely, we next examined whether blocking the KCCs could reveal a greater bumetanide effect. However, the amplitude of bumetanide’s effect was similar in the presence or absence of VU (Fig. 5C,D), indicating that the KCCs are necessary for Cl− extrusion.
Discussion
We performed somatic Cl− imaging to investigate [Cl−]i in two genetically-defined subpopulations of SCN neurons. We found that RCl was higher in both AVP+ and VIP+ neurons during the day (ZT 2 to 8) compared to the night (ZT 12 to 18), suggesting that [Cl−]i is elevated during the day. This observation is in agreement with several reports that have observed increased excitatory GABA transmission during the day and early night6, 13, 15,16,17. However, we observed Cl− influx in response to GABAA receptor activation, indicative of an inhibitory effect of GABA. Similarly, we observed large changes in RCl after application of the KCC antagonist VU, but small changes after blocking NKCC1 with bumetanide. VU increased [Cl−]i dramatically, in the range of 15 to 30 mM, suggesting that the KCCs are the major determinants of [Cl−]i in AVP+ and VIP+ SCN neurons. Therefore, our results add to a group of studies that have concluded that GABA is exclusively inhibitory in the mature SCN5, 46,47,48,49. Still, it should be remembered that the SCN is a very heterogeneous nuclei and that AVP and VIP-expressing neurons only constitute ~13% and ~9% of all SCN neurons respectively50, 51, leaving open the possibility that our study did not address the SCN neurons demonstrating excitatory GABA.
The descriptions of excitatory GABA transmission in the SCN have been riddled with discrepancies. Differences in methodology are likely to underlie some of these inconsistencies. Indeed, whole-cell, perforated-patch, cell-attached, and multi-unit recording techniques as well as Ca2+ imaging have all been used to address the polarity of GABA transmission in the SCN. The timing of inhibitory post-synaptic currents within the interspike interval is critical in determining whether inhibitory currents will speed up or slow cell firing, further highlighting the nuance of GABA transmission in the SCN4, 9, 52. The issue may also be related to the complexity of intracellular Cl− regulation itself. Besides neurotransmission, [Cl−]i is an important cellular feature linked to processes such as pH regulation, cell volume regulation, and even membrane potential12, 43, 54. Therefore, cell turgidity as well as the osmolarity and pH of solutions are all likely to influence measures of [Cl−]i. Further, [Cl−]i has been shown to change after neuronal damage, and in relation to the proximity of cells to the surface of a brain slice55, 56. Additionally, previous studies have not adequately ruled out the possibility that disinhibition underlies the observed excitatory effects of GABA transmission in the SCN. The SCN network is known to have diffuse local connectivity7, 19, 57. Therefore, polysynaptic effects must be considered when applying GABA agonists to SCN neurons. Without the inclusion of TTX in the recording media, GABA-mediated inhibition of pre-synaptic inputs could be read out as excitation in the cell of interest. Further, some of the data in support of excitatory GABA transmission has been inferred by the effects of the GABAA receptor antagonist bicuculline14, 15, 58. Regrettably, these results are confounded by the off-target effects of bicuculline, which is known to antagonize SK channels at commonly used concentrations59. Indeed, SK channels have been shown to contribute to the resting membrane potential, afterhyperpolarization and spike-frequency adaptation of SCN neurons60, 61.
We have successfully performed Cl− imaging techniques in SCN neurons, and have demonstrated their utility for monitoring Cl− flux and [Cl−]i regulation. Cl− imaging offers several advantages compared to gramicidin perforated patch recording by leaving Vm unperturbed and by allowing for the sampling of multiple neurons simultaneously. Further, the use of a genetically-encoded indicator allowed us to target specific populations of SCN neurons. Nevertheless, Cl-Sensor has room for improvement. Cl-Sensor’s sensitivity to Cl− is not optimal for normal neuronal concentrations of chloride, and the intrinsic H+ sensitivity of the indicator within a physiological pH range can be problematic.
Our methodology did not allow us to investigate subcellular differences in RCl. Indeed, intracellular Cl− gradients have been reported in several types of neurons throughout the brain (see62 for review). For example, a two-photon Cl− imaging study observed a somatodendritic chloride gradient in a class of retinal bipolar cells, concluding that Cl− is 20 mM higher in dendrites relative to the soma63. A somatodendritic Cl− gradient could explain why previous studies have shown GABA-evoked Ca2+ transients in SCN neurons15, 16, 18, supporting an excitatory role of GABA, while we have observed inhibitory Cl− influx. While dendritic depolarization may be able to activate somatic voltage-gated calcium channels, Cl− efflux at dendrites may not be registered by somatic Cl− imaging. Similarly, a somatodendritic Cl− gradient could explain why bumetanide was able to diminish GABA-evoked Ca2+ transients, but produced small changes in our measurements of somatic RCl. Higher-resolution imaging techniques will be necessary to address whether somatodendritic Cl− gradients exist in SCN neurons.
Recently, the role of the CCC’s in determining [Cl−]i has come under scrutiny by compelling two-photon Cl− imaging results which argue for the primacy of large intracellular anions in setting [Cl−]i 64. In their study, Glycks et al. observed little effect of blocking either NKCC1 or KCC2 in hippocampal and neocortical pyramidal neurons, while we found a small effect of bumetanide and a clear effect of VU. Neuron type could underlie this incongruity. Alternatively, while we monitored RCl continuously, Glycks et al. sampled RCl before and 30 minutes after application of bumetanide and VU, leaving open the possibility that secondary homeostatic mechanisms reset [Cl−]i during that time.
Although we did not observe a difference in resting RCl between AVP+ and VIP+ neurons, we did observe differential regulation of [Cl−]i between AVP+ and VIP+ neurons. We found that AVP+ and VIP+ neurons differed in their sensitivity to both VU and bumetanide. The increased sensitivity of VIP+ neurons to VU suggests that they may have lower resting [Cl−]i relative to AVP+ neurons, consistent with studies that have observed a greater prevalence of excitatory GABA transmission in the dorsal SCN6, 15, 16 as well as with recent data from two groups who, using the Cl− sensitive dye MQAE, concluded that [Cl−]i is elevated in the dorsal SCN9, 23. Previous in situ hybridization65 and immunocytochemical66 studies have described regional expression of chloride transporters in the rat SCN. Therefore, these regional differences in expression may explain the differential effects of VU and bumetanide in AVP+ and VIP+ neurons. Specifically, KCC2 expression was limited to the ventrolateral SCN, and colocalized with neurons containing GRP or VIP. Markedly, KCC2 expression was absent from the dorsomedial SCN and did not colocalize with AVP—rather, KCC3 and KCC4 were found in the dorsomedial SCN32. This histology is in agreement with our observation that VU had a larger effect in VIP+ neurons compared to AVP+ neurons. Despite the paucity of KCC2 in the dorsomedial SCN, we observed that VU increased [Cl−]i in AVP+ neurons, albeit less than it did in VIP+ neurons. The efficacy of VU in the AVP+ neurons may be explained by the non-specificity of VU for KCC244. VU may have acted on KCC3 or KCC4 in AVP+ neurons.
Generally, resting membrane potential in SCN neurons is approximately −45 mV during the night and exhibits oscillations of roughly 10 to 15 mV throughout the day61, 67. For a neuron with a Vm of −45 mV, [Cl−]i is passively distributed at approximately 15 mM. Therefore, our estimates of resting [Cl−]i (greater than 20 mM) indicate that there are constitutively-active uptake mechanisms in SCN neurons. In VIP+ neurons, blocking NKCC1 decreased [Cl−]i, supporting a role for NKCC1-mediated Cl− uptake in setting resting [Cl−]i. However, in AVP+ neurons, bumetanide caused a small increase in [Cl−]i, suggesting that other uptake mechanisms are active in AVP+ neurons. Accordingly, Choi et al. observed that GABA-induced Ca2+ transients remained in NKCC1 knockout mice15. This Cl− uptake may be mediated by the anion exchangers (AEs), which exchange intracellular bicarbonate for extracellular chloride, or could be mediated by a Cl− channel12, 43. Indeed, our results in HEPES-buffered solutions, which minimize the presence of bicarbonate transport, imply the presence of bicarbonate-dependent Cl− regulation in SCN neurons. Although generally similar, the experiments done in HEPES-buffered solution revealed several interesting differences. The effect of bumetanide in AVP+ neurons differed between solutions, and experiments done in HEPES-buffered solution revealed a day/night difference in VU’s effect on VIP+ neurons (Figs 3 and 4). These findings implicate the activity of the Na+-driven Cl-HCO3 exchanger (NDCBE) or the AE family of cotransporters in SCN neurons. Further research will be necessary to address the role of these transporters in SCN physiology.
Overall, our results demonstrate day/night and regional differences in [Cl−]i regulation and highlight the KCC family of chloride co-transporters as regulators of [Cl−]i in SCN neurons. Therefore, our results add to a growing number of studies that point to the importance of [Cl−]i in SCN function.
Methods
Animal strains and housing
Cl− imaging experiments were performed with C57BL/6 mice in which a floxed Cl-Sensor allele was inserted into the Rosa26 locus33. We crossed these mice with either AVP-IRES-Cre34 or VIP-IRES-Cre mice34, 35 to yield AVP::Cl-Sensor or VIP::Cl-Sensor mice. Tail snips were sent to an external facility for genotyping (Transnetyx, Inc). Mice were heterozygous for both the Cl-Sensor and Cre transgenes. Tissue was prepared from adult male and female mice between two and six months old. Electrophysiological experiments were performed on wild type male Wistar rats aged 3 to 9 months.
All animals were entrained to 12:12 light-dark (LD) cycles, with the time of lights on represented as ZT 0. All procedures were approved in advance by the Institutional Animal Care and Use Committee of Oregon Health and Science University, and all experiments were performed in accordance with the approved animal protocol.
Confocal microscopy of fixed tissue
Each mouse was deeply anaesthetized with isoflurane and transcardially perfused with 10 mL of phosphate buffered saline (PBS) followed by 10 mL of 4% paraformaldehyde solution in PBS (pH 7.4). The brain was removed and post-fixed for 1-2 hours at 4 °C in the same solution. After repeated washes in 0.1 M PB, the brain was blocked and secured to a vibratome insert with cyanoacrylate adhesive and agarose supports. Coronal (40 µm thick) sections were cut with a Leica vibratome in 0.1 M PB and subsequently washed in the same buffer. For optical clearing, we treated the tissue with a glycerol/0.1 M PB gradient (25% to 90%). The tissue was incubated in each solution at 4 °C with light agitation until equilibrated. After clearing, sections were transferred into a 10% glycerol/0.1 M PB solution and counterstained with DAPI. Tissue sections were transferred onto glass slides in 10% glycerol solution and the cover glass was mounted with ProLong Diamond media after removing the excess buffer. Images were taken with a Zeiss Axioskop 2 TM fluorescent microscope using AxioVision 4.8 software (Carl Zeiss MicroImaging, Inc.). Confocal micrographs consisted of several 0.4 μm thick optical sections adjusted for optimal brightness and contrast using FIJI software.
Acute slice preparation
During their light phase (ZT 1-3 for day experiments and ZT 10-12 for night experiments), animals were removed from their housing chambers, anaesthetized with isoflurane, and decapitated. The brain was quickly removed and submerged in an ice-cold slicing solution consisting of (in mM): 111 NaCl, 26 NaHCO3, 11 dextrose, 6 Na-gluconate, 4 MgCl2, 3 KCl, 1 NaH2PO4, and 0.5 CaCl2, saturated with 95% O2, 5% CO2. The brain was blocked and 175 μm thick coronal slices were prepared with a Leica VT1000S vibrating blade microtome. Slices were incubated in slicing solution for 1-4 hours at 34 °C before recording.
Cl− imaging from acute SCN slices
During image acquisition, slices were perfused at 1–2 mL/min with an artificial cerebrospinal fluid (aCSF) with Cl− adjusted to the physiological concentration (122 mM; ref. 68). aCSF contained (in mM): 114 NaCl, 26 NaHCO3, 11 dextrose, 6 Na-gluconate, 2.7 KCl, 2 CaCl2, 1 MgCl2, and 1 NaH2PO4, saturated with 95% O2, 5% CO2. Where indicated, experiments were performed with a HEPES-buffered aCSF containing (in mM): 114 NaCl, 22 Na-gluconate, 12.5 HEPES, 7.5 Na-HEPES, 5 dextrose, 2.7 KCl, 2 CaCl2, 1 MgCl2, and 1 NaH2PO4. pH was adjusted to 7.40 with NaOH, and the solution was gassed with 100% O2. The bath was maintained at 34 °C for all experiments and tetrodotoxin (TTX) was included in recording solutions to eliminate any possible polysynaptic effects of GABA agonists.
Experiments were performed during ZT 2–8 for ‘day’ mice and ZT 12–18 for ‘night’ mice. Cl-Sensor fluorescent imaging was performed using epifluorescent methodology similar to that described by Friedel et al.69. Excitation light was supplied by a monochrometer (Polychrome IV; Till Photonics) providing 10 nm bandwidth output. Excitation at 500 nm preceded excitation at 436 nm to promote Cl-Sensor photostability69. Excitation duration ranged from 20 to 200 ms, with the excitation at 500 nm 1.5 times longer than that at 436 nm in order to obtain similar intensity values. The fluorescent signal passed through a double bandpass emission filter [470(24) + 535(30) nm] (Chroma Technology Corporation). Imaging was performed with an upright fluorescent microscope and a 63x water-immersion objective, NA 0.90 (Leica). Images were acquired with a charge-coupled device camera (CCD, ORCA-ER 12 bit level; Hamamatsu). Camera gain was set to 100, and binning was 4 × 4. Equipment control and image processing were performed with Metafluor software (Molecular Devices). Regions of interest (ROI) were defined around neuronal soma, and a dim region of the field of view was selected as background. Background values were subtracted for each wavelength independently. Because the YFP moiety of Cl-Sensor is quenched by Cl− ions, we choose to plot the emission following 436 nm excitation over that at 500 nm excitation so that RCl would be a proxy for [Cl−]i, with a higher ratio indicating higher [Cl−]i.
When sampling at 2 and 5 second intervals, an exposure-dependent increase of RCl was observed, most likely due to an accumulation of Cl-Sensor’s YFP moiety in an inactivated state69. To correct for this instability, we fit our data with a single-exponential function, and subtracted the time-dependent component. Despite this correction, we observed that steady-state RCl remained sensitive to exposure duration. We corrected for this exposure-dependent trend in each condition (AVP+ day, AVP+ night, VIP+ day, VIP+ night) independently in order to avoid any assumptions about the similarities of baseline RCl across conditions. All values were adjusted to a 500 nm exposure of 100 ms.
Calibration of Cl-Sensor and estimation of [Cl−]i
In order to relate RCl to [Cl−]i, it was necessary to construct a calibration curve. Cl-Sensor was calibrated using a 0 mM Cl− solution consisting of (in mM): 120 Na-gluconate, 26 NaHCO3, 11 dextrose, 2.7 K-gluconate, 2 Ca-gluconate, 1 MgSO4, and 1 NaH2PO4, saturated with 95% O2, 5% CO2. This solution was mixed with aCSF to produce solutions of 0, 4, 20, 40, 60, and 80, and 123 mM Cl−. 50 μM β-escin was added to all calibration solutions to permeabilize cells. AVP::Cl-Sensor and VIP::Cl-Sensor day and night-entrained mice were used for analysis. RCl values were corrected for exposure as discussed above. Average steady-state RCl was plotted against Cl− concentration (Supplementary Fig. 1) and calibration data was fit with the following logistic dose-response sigmoidal curve:
Where R Cl is the fluorescence intensity ratio (F436/F500) for chloride, K d is the dissociation constant for Cl− binding, R min and R max are the minimum and maximum asymptotic values of R Cl , and p is the Hill coefficient33. To obtain estimates of [Cl−]i, we re-arranged the equation for [Cl−]i:
After fitting the curve, we obtained the following values: K d = 108.8 mM, R min = 0.98, R max = 2.92 and p = 2.91 (Supplementary Fig. 1). Our K d is considerably higher than previously-reported values33, 70, 71. We also observed substantial variability in RCl at specific Cl− concentrations between calibration experiments. Furthermore, RCl was fairly non-linear in our range of operation (see Supplementary Fig. 1; our RCl values were generally between 1.0 and 1.3). For these reasons, we elected to leave fluorescent measurements in values of RCl instead of converting them into estimates of [Cl−]i in subsequent analysis.
Perforated-patch electrophysiology
Brain slices were prepared as above. Recordings were performed with an Axopatch-1D amplifier (Axon Instruments), filtered at 2 kHz, digitized at 5 kHz, and acquired with Patchmaster v5.3 (HEKA Elektronik). Pipette solution contained (in mM): 120 KCl, 20 K-gluconate, 15 HEPES, 2 NaCl, 1 EGTA and either 0.2 of Lucifer Yellow or Texas Red. pH was adjusted to 7.26 with KOH. Gramicidin (Sigma) was dissolved in DMSO to a concentration of 50 mg/mL, aliquoted, and frozen. Before an experiment, this stock solution was diluted to a final pipette concentration of 30–100 μg/mL. A drop of gramicidin-free pipette solution was first applied to the backend of the pipette. After capillary action filled the pipette tip, the pipette was back-filled with the gramicidin-containing solution moments before submersion into the recording chamber. After gigaseal formation, series resistance (Rs) was monitored with a −5 mV voltage step to monitor the progress of perforation. Only recordings with a Rs less than 100 MΩ were used for experiments. Cells were voltage clamped at −60 mV and cells with holding currents less than −30 pA were discarded.
EGABA was determined using voltage ramp protocols. Every 10 seconds, a 400 ms voltage ramp protocol (ΔV ≅ 60 mV) was executed 100 ms after puff-application of 1 mM GABA. A current trace recorded in the absence of GABA was subtracted from currents obtained in the presence of GABA. The subtracted current trace was then plotted against the ramp command potential, and EGABA was recorded as the x-intercept. EGABA was not corrected for Rs or liquid junction potentials.
Drugs
All drugs used in this study were acquired from Tocris Bioscience. Bumetanide and VU0240551 were dissolved in DMSO, stored as 10 mM stock solutions, and applied through the bath at 10 μM. A 100 mM stock of isoguvacine in water was diluted in aCSF to 1 mM and focally applied (5 psi) through a micropipette connected to a Picospritzer (General Valve Corporation).
Statistics and analysis
Igor Pro (Version 6.22 A; Wavemetrics) was used for plotting, curve-fitting and data analysis. Data are presented as the mean ± standard error. For imaging experiments, generalized estimating equations (GEE) were used to determine statistical significance72. GEE models are similar to ANOVA and general linear models in that they estimate a mean response, except standard errors are adjusted for clustered or correlated measurements that originate from multiple observations made from the same brain slice. Therefore, each brain slice is treated as an independent measure, while the ROIs influence the average and standard error of each experiment. GEE test statistics are based on chi-square or z-statistics rather than F- and t-distributions. When comparing drug effects between HEPES-buffered and bicarbonate-buffered solutions, we formed z-statistics equal to the difference between the estimated effects from each separate GEE model (one for each solution) divided by the standard error of the difference. Significance level was Bonferroni-adjusted for these comparisons. For electrophysiology experiments, we used the Student’s t-test. For all tests, a p-value less than 0.05 was considered to be statistically significant.
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Moldavan, M. G., Irwin, R. P. & Allen, C. N. Presynaptic GABAB receptors Regulate Retinohypothalamic Tract Synaptic Transmission by inhibiting Voltage-Gated Ca2+ Channels. Journal of neurophysiology 95, 3727–3741 (2006).
Gillespie, C. F., Huhman, K. L., Babagbemi, T. O. & Albers, H. E. Bicuculline increases and muscimol reduces the phase-delaying effects of light and VIP/PHI/GRP in the suprachiasmatic region. Journal of biological rhythms 11, 137–144 (1996).
Gillespie, C. F., Mintz, E. M., Marvel, C. L., Huhman, K. L. & Albers, H. E. GABAA and GABAB agonists and antagonists alter the phase-shifting effects of light when microinjected into the suprachiasmatic region. Brain Res 759, 181–189 (1997).
Kononenko, N. I. & Dudek, F. E. Mechanism of irregular firing of suprachiasmatic nucleus neurons in rat hypothalamic slices. Journal of neurophysiology 91, 267–273 (2004).
Liu, C. & Reppert, S. M. GABA synchronizes clock cells within the suprachiasmatic circadian clock. Neuron 25, 123–128 (2000).
Albus, H., Vansteensel, M. J., Michel, S., Block, G. D. & Meijer, J. H. A GABAergic mechanism is necessary for coupling dissociable ventral and dorsal regional oscillators within the circadian clock. Curr Biol 15, 886–893 (2005).
Freeman, G. M. Jr., Krock, R. M., Aton, S. J., Thaben, P. & Herzog, E. D. GABA Networks Destabilize Genetic Oscillations in the Circadian Pacemaker. Neuron 78, 799–806 (2013).
Evans, J. A., Leise, T. L., Castanon-Cervantes, O. & Davidson, A. J. Dynamic interactions mediated by nonredundant signaling mechanisms couple circadian clock neurons. Neuron 80, 973–983 (2013).
DeWoskin, D. et al. Distinct roles for GABA across multiple timescales in mammalian circadian timekeeping. Proceedings of the National Academy of Sciences of the United States of America 112, E3911–3919 (2015).
Gamba, G. Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters. Physiological reviews 85, 423–493 (2005).
Ben-Ari, Y. et al. Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever! Frontiers in cellular neuroscience 6, 35 (2012).
Blaesse, P., Airaksinen, M. S., Rivera, C. & Kaila, K. Cation-chloride cotransporters and neuronal function. Neuron 61, 820–838 (2009).
Wagner, S., Castel, M., Gainer, H. & Yarom, Y. GABA in the mammalian suprachiasmatic nucleus and its role in diurnal rhythmicity. Nature 387, 598–603 (1997).
De Jeu, M. & Pennartz, C. M. A. Circadian modulation of GABA function in the rat suprachiasmatic nucleus: excitatory effects during the night phase. Journal of neurophysiology 87, 834–844 (2002).
Choi, H. J. et al. Excitatory Actions of GABA in the Suprachiasmatic Nucleus. J Neurosci 28, 5450–5459 (2008).
Irwin, R. P. & Allen, C. N. GABAergic signaling induces divergent neuronal Ca(2+) responses in the suprachiasmatic nucleus network. The European journal of neuroscience 30, 1462–1475 (2009).
Alamilla, J., Perez-Burgos, A., Quinto, D. & Aguilar-Roblero, R. Circadian modulation of the cl(−) equilibrium potential in the rat suprachiasmatic nuclei. BioMed research international 2014, 424982 (2014).
Farajnia, S., van Westering, T. L., Meijer, J. H. & Michel, S. Seasonal induction of GABAergic excitation in the central mammalian clock. Proceedings of the National Academy of Sciences of the United States of America 111, 9627–9632 (2014).
Fan, J. et al. Vasoactive intestinal polypeptide (VIP)-expressing neurons in the suprachiasmatic nucleus provide sparse GABAergic outputs to local neurons with circadian regulation occurring distal to the opening of postsynaptic GABAA ionotropic receptors. J Neurosci 35, 1905–1920 (2015).
Wagner, S., Sagiv, N. & Yarom, Y. GABA-induced current and circadian regulation of chloride in neurones of the rat suprachiasmatic nucleus. The Journal of physiology 537, 853–869 (2001).
Itri, J., Michel, S., Waschek, J. A. & Colwell, C. S. Circadian rhythm in inhibitory synaptic transmission in the mouse suprachiasmatic nucleus. Journal of neurophysiology 92, 311–319 (2004).
Gompf, H. S. & Allen, C. N. GABAergic synapses of the suprachiasmatic nucleus exhibit a diurnal rhythm of short-term synaptic plasticity. European Journal of Neuroscience 19, 2791–2798 (2004).
Myung, J. et al. GABA-mediated repulsive coupling between circadian clock neurons in the SCN encodes seasonal time. Proceedings of the National Academy of Sciences of the United States of America 112, E3920–3929 (2015).
Bormann, J., Hamill, O. P. & Sakmann, B. Mechanism of anion permeation through channels gated by glycine and G-aminobutyric acid in mouse cultured spinal cord neurones. The Journal of physiology (london) 385, 243–286 (1987).
Kaila, K. & Voipio, J. Postsynaptic fall in intracellular pH induced by GABA-activated bicarbonate conductance. Nature 330, 163–165 (1987).
Farrant, M. & Kaila, K. The cellular, molecular and ionic basis of GABA(A) receptor signalling. Progress in brain research 160, 59–87 (2007).
Lu, J., Karadsheh, M. & Delpire, E. Developmental regulation of the neuronal-specific isoform of K-Cl cotransporter KCC2 in postnatal rat brains. Journal of neurobiology 39, 558–568 (1999).
Williams, J. R., Sharp, J. W., Kumari, V. G., Wilson, M. & Payne, J. A. The neuron-specific K-Cl cotransporter, KCC2. Antibody development and initial characterization of the protein. The Journal of biological chemistry 274, 12656–12664 (1999).
Mercado, A., Broumand, V., Zandi-Nejad, K., Enck, A. H. & Mount, D. B. A C-terminal domain in KCC2 confers constitutive K+ -Cl- cotransport. The Journal of biological chemistry 281, 1016–1026 (2006).
Strange, K., Singer, T. D., Morrison, R. & Delpire, E. Dependence of KCC2 K-Cl cotransporter activity on a conserved carboxy terminus tyrosine residue. Am J Physiol Cell Physiol 279, C860–867 (2000).
Song, L. et al. Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. Brain Res Mol Brain Res 103, 91–105 (2002).
Belenky, M. A. et al. Cell-type specific distribution of chloride transporters in the rat suprachiasmatic nucleus. Neuroscience 165, 1519–1537 (2010).
Batti, L. et al. Transgenic mouse lines for non-invasive ratiometric monitoring of intracellular chloride. Front Mol Neurosci 6, 11 (2013).
Harris, J. A. et al. Anatomical characterization of Cre driver mice for neural circuit mapping and manipulation. Frontiers in neural circuits 8, 76 (2014).
Taniguchi, H. et al. A resource of cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron 71, 995–1013 (2011).
Van den Pol, A. N. Gamma-aminobutyrate, gastrin releasing peptide, serotonin, somatostatin, and vasopressin: ultrastructural immunocytochemical localization in presynaptic axons in the suprachiasmatic nucleus. Neuroscience 17, 643–659 (1986).
Haam, J. et al. GABA Is Excitatory in Adult Vasopressinergic Neuroendocrine Cells. J Neurosci 32, 572–582 (2012).
Arosio, D. & Ratto, G. M. Twenty years of fluorescence imaging of intracellular chloride. Frontiers in cellular neuroscience 8, 258 (2014).
Mukhtarov, M. et al. Calibration and functional analysis of three genetically encoded Cl(-)/pH sensors. Front Mol Neurosci 6, 9 (2013).
Raimondo, J. V. et al. A genetically-encoded chloride and pH sensor for dissociating ion dynamics in the nervous system. Frontiers in cellular neuroscience 7, 202 (2013).
Staley, K. J. & Proctor, W. R. Modulation of mammalian dendritic GABA(A) receptor function by the kinetics of Cl- and HCO3- transport. The Journal of physiology 519, 693–712 (1999).
Lamsa, K. & Taira, T. Use-dependent shift from inhibitory to excitatory GABAA receptor action in SP-O interneurons in the rat hippocampal CA3 area. Journal of neurophysiology 90, 1983–1995 (2003).
Doyon, N., Vinay, L., Prescott, S. A. & De Koninck, Y. Chloride Regulation: A Dynamic Equilibrium Crucial for Synaptic Inhibition. Neuron 89, 1157–1172 (2016).
Delpire, E. et al. Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2. Proceedings of the National Academy of Sciences of the United States of America 106, 5383–5388 (2009).
Russell, J. M. Sodium-potassium-chloride cotransport. Physiological reviews 80, 211–276 (2000).
Liou, S. Y. & Albers, H. E. Single unit response of neurons within the hamster suprachiasmatic nucleus to GABA and low chloride perfusate during the day and night. Brain research bulletin 25, 93–98 (1990).
Mason, R., Biello, S. M. & Harrington, M. E. The effects of GABA and benzodiazepines on neurones in the suprachiasmatic nucleus (SCN) of Syrian hamsters. Brain Res 552, 53–57 (1991).
Bos, N. P. A. & Mirmiran, M. Effects of excitatory and inhibitory amino acids on neuronal discharges in the cultured suprachiasmatic nucleus. Brain research bulletin 31, 67–72 (1993).
Chen, G., Trombley, P. & Van den Pol, A. N. Excitatory actions of GABA in developing rat hypothalamic neurones. The Journal of physiology (london) 494, 451–464 (1996).
Welsh, D. K., Takahashi, J. S. & Kay, S. A. Suprachiasmatic nucleus: cell autonomy and network properties. Annual review of physiology 72, 551–577 (2010).
Lee, I. T. et al. Neuromedin s-producing neurons act as essential pacemakers in the suprachiasmatic nucleus to couple clock neurons and dictate circadian rhythms. Neuron 85, 1086–1102 (2015).
Tremere, L. A., Pinaud, R., Irwin, R. P. & Allen, C. N. Postinhibitory rebound spikes are modulated by the history of membrane hyperpolarization in the SCN. The European journal of neuroscience 28, 1127–1135 (2008).
Delpire, E. & Staley, K. J. Novel determinants of the neuronal Cl- concentration. The Journal of physiology, (2014).
Chamma, I., Chevy, Q., Poncer, J. C. & Levi, S. Role of the neuronal K-Cl co-transporter KCC2 in inhibitory and excitatory neurotransmission. Frontiers in cellular neuroscience 6, 5 (2012).
Dzhala, V., Valeeva, G., Glykys, J., Khazipov, R. & Staley, K. Traumatic alterations in GABA signaling disrupt hippocampal network activity in the developing brain. J Neurosci 32, 4017–4031 (2012).
Kahle, K. T. et al. Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol 4, 490–503 (2008).
Campos, L. M., Cruz-Rizzolo, R. J., Watanabe, I. S., Pinato, L. & Nogueira, M. I. Efferent projections of the suprachiasmatic nucleus based on the distribution of vasoactive intestinal peptide (VIP) and arginine vasopressin (AVP) immunoreactive fibers in the hypothalamus of Sapajus apella. Journal of chemical neuroanatomy 57-58, 42–53 (2014).
Gribkoff, V. K. et al. A reexamination of the role of GABA in the mammalian suprachiasmatic nucleus. Journal of biological rhythms 14, 126–130 (1999).
Khawaled, R., Bruening-Wright, A., Adelman, J. P. & Maylie, J. Bicuculline block of small-conductance calcium-activated potassium channels. Pflugers Archiv. European Journal of Physiology 438, 314–321 (1999).
Teshima, K., Kim, S. H. & Allen, C. N. Characterization of an apamin-sensitive potassium current in suprachiasmatic nucleus neurons. Neuroscience 120, 65–73 (2003).
Belle, M. D., Diekman, C. O., Forger, D. B. & Piggins, H. D. Daily electrical silencing in the mammalian circadian clock. Science 326, 281–284 (2009).
Wright, R., Raimondo, J. V. & Akerman, C. J. Spatial and temporal dynamics in the ionic driving force for GABA(A) receptors. Neural Plast 2011, 728395 (2011).
Duebel, J. et al. Two-photon imaging reveals somatodendritic chloride gradient in retinal ON-type bipolar cells expressing the biosensor Clomeleon. Neuron 49, 81–94 (2006).
Glykys, J. et al. Local impermeant anions establish the neuronal chloride concentration. Science 343, 670–675 (2014).
Kanaka, C. et al. The differential expression patterns of messenger RNAs encoding K-Cl cotransporters (KCC1,2) and Na-K-2Cl cotransporter (NKCC1) in the rat nervous system. Neuroscience 104, 933–946 (2001).
Belenky, M. A., Yarom, Y. & Pickard, G. E. Heterogeneous expression of gamma-aminobutyric acid and gamma-aminobutyric acid-associated receptors and transporters in the rat suprachiasmatic nucleus. The Journal of comparative neurology 506, 708–732 (2008).
Kuhlman, S. J. & McMahon, D. G. Rhythmic regulation of membrane potential and potassium current persists in SCN neurons in the absence of environmental input. The European journal of neuroscience 20, 1113–1117 (2004).
Schrock, H. & Kuschinsky, W. Cerebrospinal fluid ionic regulation, cerebral blood flow, and glucose use during chronic metabolic alkalosis. The American journal of physiology 257, H1220–1227 (1989).
Friedel, P., Bregestovski, P. & Medina, I. Improved method for efficient imaging of intracellular Cl(−) with Cl-Sensor using conventional fluorescence setup. Front Mol Neurosci 6, 7 (2013).
Markova, O., Mukhtarov, M., Real, E., Jacob, Y. & Bregestovski, P. Genetically encoded chloride indicator with improved sensitivity. Journal of neuroscience methods 170, 67–76 (2008).
Waseem, T., Mukhtarov, M., Buldakova, S., Medina, I. & Bregestovski, P. Genetically encoded Cl-Sensor as a tool for monitoring of Cl-dependent processes in small neuronal compartments. Journal of neuroscience methods (2010).
Zeger, S. L. & Liang, K. Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121–130 (1986).
Acknowledgements
We thank Dr. Piotr Bregestovski for kindly providing us with the Cre-inducible Rosa26::Cl-Sensor mice and Mike Lasarev for help with statistical analysis. Olga Cravetchi managed the mouse breeding and genotyping. The work was supported by National Institutes of Health (NIH) grant NS036607 and a Medical Research Foundation of Oregon grant to CNA.
Author information
Authors and Affiliations
Contributions
N.J.K. and C.N.A. designed the experiments. N.J.K. performed the experiments and analyzed the data. N.J.K. and C.N.A. wrote and edited the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Klett, N.J., Allen, C.N. Intracellular Chloride Regulation in AVP+ and VIP+ Neurons of the Suprachiasmatic Nucleus. Sci Rep 7, 10226 (2017). https://doi.org/10.1038/s41598-017-09778-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-09778-x
- Springer Nature Limited
This article is cited by
-
One seasonal clock fits all?
Journal of Comparative Physiology A (2024)
-
Compensatory ion transport buffers daily protein rhythms to regulate osmotic balance and cellular physiology
Nature Communications (2021)
-
Role of GABA in the regulation of the central circadian clock of the suprachiasmatic nucleus
The Journal of Physiological Sciences (2018)